Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 1783

Sort by

Sort Order Select

Journal Articles

A contemporary downtrend in chronic GVHD?

Najla El Jurdi, Steven Z. Pavletic

Blood Adv (2024) 8 (22): 5875–5877.

https://doi.org/10.1182/bloodadvances.2024014586

Published: 2024

Journal Articles

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry A Paul, Fei Guo, Jason Grayson, Anna Ivanina-Foureau, Mauricio Pineda-Roman, Cindy Varga, Reed Friend, Christopher J Ferreri, Xhevahire Begic, Sarah Norek, Tiffany Drennan, Michelle B Anderson, James T Symanowski, Peter M Voorhees, Saad Z Usmani

Blood Adv bloodadvances.2024014417.

https://doi.org/10.1182/bloodadvances.2024014417

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Blood Adv bloodadvances.2024013640.

https://doi.org/10.1182/bloodadvances.2024013640

Published: 2024

Includes: Supplemental data

Journal Articles

Incidence and Characterization of Secondary CNS Lymphoma in 1,972 Patients with DLBCL - A Danish Nationwide Cohort Study

Elisabeth Reuben Tolley, Dr, Torsten Holm Nielsen, Ditte Stampe Hersby, Simon Østergaard, Malin Rasmussen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Karina Moeslund Egeberg, Laura Mors Haunstrup, Christian Brieghel, Carsten Utoft Niemann, Tarec Christoffer El Galaly, Lars Møller Pedersen

Blood Adv bloodadvances.2024014404.

https://doi.org/10.1182/bloodadvances.2024014404

Published: 2024

Includes: Supplemental data

Journal Articles

T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.

Talha Badar, Keith Knutson, James M Foran, Naseema Gangat, Kevin D Pavelko, Scott H Kaufmann, Mark R Litzow, Hemant S. Murthy, Davitte Cogen, Margaret Ushman, Arini Arsana, Aref Al-Kali, Hassan B Alkhateeb, Ayalew Tefferi, Mrinal M. Patnaik, Mithun Vinod Shah

Blood Adv bloodadvances.2024014553.

https://doi.org/10.1182/bloodadvances.2024014553

Published: 2024

Includes: Supplemental data

Journal Articles

Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia

Maria Ebbesen Sørum, Ulrika Boulund, Silvia De Pietri, Sarah Weischendorff, Christian Enevold, Mathias Rathe, Bodil Als-Nielsen, Henrik Hasle, Sünje Johanna Pamp, Jakob Stokholm, Klaus Müller

Blood Adv bloodadvances.2024013986.

https://doi.org/10.1182/bloodadvances.2024013986

Published: 2024

Includes: Supplemental data

Journal Articles

Psychological burden and depressive symptoms in caregivers of hemato-oncological patients: the role of medical visits

Ali Abed Al Wahad, Roni Elran-Barak, Marina Furer, Gihan Abu Kamir, Netanel A. Horowitz

Blood Adv (2024) 8 (22): 5917–5924.

https://doi.org/10.1182/bloodadvances.2024012915

Published: 2024

Journal Articles

Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia

Marlise R. Luskin, Shai Shimony, Julia H. Keating, Eric S Winer, Jacqueline S. Garcia, Richard M. Stone, Elias J. Jabbour, Yael Flamand, Kristen Stevenson, Jeremy Adam Ryan, Zhihong Zeng, Anthony Letai, Marina Y. Konopleva, Nitin Jain, Daniel J DeAngelo

Blood Adv bloodadvances.2024014405.

https://doi.org/10.1182/bloodadvances.2024014405

Published: 2024

Includes: Supplemental data

Journal Articles

Decreasing chronic graft-versus-host disease rates in all populations

Paul A. Carpenter, Ted A. Gooley, Julie Boiko, Catherine J. Lee, Lauri M. Burroughs, Rohtesh Mehta, Rachel B. Salit, Neel S. Bhatt, Elizabeth Krakow, Ann E. Dahlberg, Albert C. Yeh, Corinne N. Summers, Masumi Ueda Oshima, Effie W. Petersdorf, Phuong Vo, Laura Connelly-Smith, Stephanie J. Lee

Blood Adv (2024) 8 (22): 5829–5837.

https://doi.org/10.1182/bloodadvances.2024012722

Published: 2024

Journal Articles

Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollment

Vaishali Sanchorawala, Bruna Barroso, Anthony Shelton, Elise Goetz, Lisa Mendelson, Tracy Joshi, Natasha Burke, J. Mark Sloan, Andrew Staron

Blood Adv (2024) 8 (22): 5826–5828.

https://doi.org/10.1182/bloodadvances.2024014262

Published: 2024

Journal Articles

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Joseph E. Maakaron, Adam Asch, Leslie Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Gal Hacohen-Kleiman, Yanan Huo, Yi Zhang, Camille Renard, Sonali M. Smith, Ranjana Advani

Blood Adv (2024) 8 (22): 5864–5874.

https://doi.org/10.1182/bloodadvances.2024013338

Published: 2024

Includes: Supplemental data

Journal Articles

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana Advani, Mark Roschewski

Blood Adv (2024) 8 (22): 5855–5863.

https://doi.org/10.1182/bloodadvances.2024013277

Published: 2024

Includes: Supplemental data

Journal Articles

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

Chenyu Lin, Anand A. Patel, Dezheng Huo, Theodore Karrison, Koen van Besien, John Godwin, Dorie Sher, Howie Weiner, Margaret Green, James L. Wade, III, Rebecca Klisovic, Maria R. Baer, Richard A. Larson, Wendy Stock, Olatoyosi Odenike

Blood Adv (2024) 8 (22): 5735–5743.

https://doi.org/10.1182/bloodadvances.2024013215

Published: 2024

Includes: Supplemental data

Journal Articles

Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia

Leo Ruhnke, Marius Bill, Sven Zukunft, Jan-Niklas Eckardt, Silvia Schäfer, Sebastian Stasik, Maher Hanoun, Thomas Schroeder, Lars Fransecky, Björn Steffen, Stefan W Krause, Sebastian Scholl, Andreas Hochhaus, Tim Sauer, Sabrina Kraus, Kerstin Schäfer-Eckart, Martin Kaufmann, Edgar Jost, Tim H. Brümmendorf, Christoph Schliemann, Jan-Henrik Mikesch, Utz Krug, Mathias Hänel, Anke Morgner, Markus Schaich, Andreas Neubauer, Roland Repp, Dirk Niemann, Ruth Seggewiss-Bernhardt, Achim Meinhardt, Johannes Kullmer, Ulrich Kaiser, Wolfgang Blau, Alexander Kiani, Götz Ulrich Grigoleit, Aristoteles Giagounidis, Alexander Arthur Wurm, Heidi Altmann, Jan Moritz M Middeke, Johannes Schetelig, Carsten Müller-Tidow, Friedrich Stölzel, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser, Christian Thiede, Christoph Röllig

Blood Adv bloodadvances.2024013304.

https://doi.org/10.1182/bloodadvances.2024013304

Published: 2024

Includes: Supplemental data

Journal Articles

The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial

Simon J. Stanworth, David Churchill, Samaher Sweity, Tom Holmes, Cara Hudson, Rosemary Brown, Stephanie J. Lax, Joanne Murray, Helen Spiby, Noemi Roy, Andrew Farmer, Chris Gale, Elise Crayton, Fabiana Lorencatto, James Griffiths, Joanne Mullings, Sara Last, Marian Knight

Blood Adv (2024) 8 (21): 5683–5694.

https://doi.org/10.1182/bloodadvances.2024013408

Published: 2024

Includes: Supplemental data

Journal Articles

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Emma Verner, Amanda Johnston, Nalini Pati, Eliza A. Hawkes, Hui-Peng Lee, Tara Cochrane, Chan Yoon Cheah, Robin Filshie, Duncan Purtill, Hanlon Sia, Anoop K. Enjeti, Christina Brown, Nicholas Murphy, Jennifer Curnow, Kenneth Lee, Maher K. Gandhi, Mannu Walia, Belinda E. Butcher, Judith Trotman

Blood Adv (2024) 8 (21): 5674–5682.

https://doi.org/10.1182/bloodadvances.2024014035

Published: 2024

Includes: Supplemental data

Journal Articles

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Dino Mehic, Stéphanie E. Reitsma, Claire de Moreuil, Helmuth Haslacher, Maximilian C. Koeller, Bas de Laat, Cihan Ay, Ingrid Pabinger, Alisa S. Wolberg, Johanna Gebhart

Blood Adv (2024) 8 (21): 5663–5673.

https://doi.org/10.1182/bloodadvances.2024012855

Published: 2024

Includes: Supplemental data

Journal Articles

Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease

Blood Adv bloodadvances.2024013926.

https://doi.org/10.1182/bloodadvances.2024013926

Published: 2024

Includes: Supplemental data

Journal Articles

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

Sherif M. Badawy, Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Leo Lin, Anna Rozova, Sujit Sheth

Blood Adv (2024) 8 (21): 5641–5649.

https://doi.org/10.1182/bloodadvances.2023012316

Published: 2024

Journal Articles

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study

Blood Adv (2024) 8 (21): 5571–5578.

https://doi.org/10.1182/bloodadvances.2024013152

Published: 2024

Includes: Supplemental data

NARROW

A contemporary downtrend in chronic GVHD?

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Incidence and Characterization of Secondary CNS Lymphoma in 1,972 Patients with DLBCL - A Danish Nationwide Cohort Study

T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.

Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia

Psychological burden and depressive symptoms in caregivers of hemato-oncological patients: the role of medical visits

Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia

Decreasing chronic graft-versus-host disease rates in all populations

Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollment

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia

The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only